TITLE

Optimization of HAART with genetic algorithms and agent-based models of HIV infection

AUTHOR(S)
F. Castiglione; F. Pappalardo; M. Bernaschi; S. Motta
PUB. DATE
December 2007
SOURCE
Bioinformatics;Dec2007, Vol. 23 Issue 24, p3350
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Motivation: Highly Active AntiRetroviral Therapies (HAART) can prolong life significantly to people infected by HIV since, although unable to eradicate the virus, they are quite effective in maintaining control of the infection. However, since HAART have several undesirable side effects, it is considered useful to suspend the therapy according to a suitable schedule of Structured Therapeutic Interruptions (STI). In the present article we describe an application of genetic algorithms (GA) aimed at finding the optimal schedule for a HAART simulated with an agent-based model (ABM) of the immune system that reproduces the most significant features of the response of an organism to the HIV-1 infection. Results: The genetic algorithm helps in finding an optimal therapeutic schedule that maximizes immune restoration, minimizes the viral count and, through appropriate interruptions of the therapy, minimizes the dose of drug administered to the simulated patient. To validate the efficacy of the therapy that the genetic algorithm indicates as optimal, we ran simulations of opportunistic diseases and found that the selected therapy shows the best survival curve among the different simulated control groups. Availability: A version of the C-ImmSim simulator is available at http://www.iac.cnr.it/~filippo/c-ImmSim.html Contact: f.castiglione@iac.cnr.it
ACCESSION #
27793414

 

Related Articles

  • Diplopia in a Patient with HIV Infection. Dhillon, Wishwdeep S.; Shah, Tushar // New England Journal of Medicine;4/15/2010, Vol. 362 Issue 15, pe52 

    The article presents a case study of a man with human immunodeficiency virus (HIV) infection who was receiving highly active antiretroviral therapy and found to have diplopia and headache for a week.

  • Standing in the Way of Eradication: HIV-1 Infection and Treatment in the Male Genital Tract. Shehu-Xhilaga, Miranda; De Kretser, David; Dejucq-Rainsford, Nathalie; Hedger, Mark // Current HIV Research;Oct2005, Vol. 3 Issue 4, p345 

    As a result of the introduction of the Highly Active Antiretroviral Therapy (HAART) many HIV-1 infected individuals are able to live an improved and extended life style that can include the prospect of having children. Problematically, the male reproductive organs may contribute infected cells...

  • Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India. Tripathy, S.; Anand, A.; Inamdar, V.; Manoj, M. M.; Khillare, K. M.; Datye, A. S.; Iyer, R.; Kanoj, D. M.; Thakar, M.; Kale, V.; Pereira, M.; Risbud, A. R. // Indian Journal of Medical Research;May2011, Vol. 133 Issue 5, p521 

    Background & objectives: in the Revised National Tuberculosis Control Programme (RNTCP) in India prior to 2005, TB patients were offered standard DOTS regimens without knowledge of HIV status. Consequently such patients did not receive anti-retroviral therapy (ART) and the influence of...

  • Early drug therapy reduces HIV transmission, study says. Taylor, Billy // Pink Paper;5/13/2011, p1 

    The article offers information on the HIV Prevention Trials Network's controlled trial conducted across Africa, Asia and the Americas, known as HPTN 052, which shows that treating an HIV-positive person with anti-retroviral therapy can reduce the risk of sexual transmission of HIV to an...

  • Implementation and Effectiveness of Antiretroviral Therapy in Greenland. Lohse, Nicolai; Ladefoged, Karin; Obel, Niels // Emerging Infectious Diseases;Jan2008, Vol. 14 Issue 1, p56 

    Analyses from the Danish HIV Cohort Study showed that, despite comparable economic means and general education of healthcare personnel, antiretroviral treatment of HIV in Greenland began later and has been implemented at a slower pace with lower therapeutic effectiveness than in Denmark....

  • Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa. Mills, Edward J.; Nabiryo, Christine // PLoS Medicine;Jan2013, Vol. 10 Issue 1, p1 

    An introduction is presented in which the editors discuss the article on the issue concerning the study which explores the antiretroviral treatment of patients with HIV and AIDS in Africa.

  • Treatment of HIV/AIDS in resource-limited settings: Exploring the idea of universal test and treat. van der Horst, Charles; Herce, Michael // Infectious Disease News;Aug2013, Vol. 26 Issue 8, p14 

    The author presents his views on the guidelines released by the World Health Organization on the use of antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infection and argues that it is time to use the test-and-treat approach to treat HIV.

  • Nevirapine.  // Reactions Weekly;10/23/2010, Issue 1324, p28 

    The article describes the case of a 40-year-old woman with HIV infection who presented with maculopapular exanthema following administration with an antiretroviral three-drug treatment plus levofloxacin, referencing a study presented at the 10th Annual Meeting of the International Society of...

  • Antiretroviral therapy of late presenters with advanced HIV disease. Manuel Battegay; Jan Fehr; Ursula Fl├╝ckiger; Luigia Elzi // Journal of Antimicrobial Chemotherapy (JAC);Jul2008, Vol. 62 Issue 1, p41 

    Potent antiretroviral therapy (ART) has dramatically improved the prognosis of HIV-1-infected individuals. However, 10% to 30% of patients in Western countries still present late for care, when CD4 T cells are below 200 cells/mm3 and symptomatic HIV disease has occurred. Clinical considerations...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics